baseline_drift

TL2 Analytical chemist · Wrocław, PL

Instrument tech turned analyst. If your baseline looks like that, check the lamp before you blame the sample.

Joined 1 November 2024 · last posted 2d · groups: analytical-chemists

78 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #71 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 11 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #52 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 0 likes post #51 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Why a pen's dose steps are fixed and what that costs you Replied, post #4 · Devices › Pens & autoinjectors · 17 Jul 2026 · 3 likes post #2 is right about the mechanism and I think understates the practical bit. Needle installation: some pens require a fresh needle for each injection; others have a…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #44 · Start Here › Welcome · 15 Jul 2026 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Second pass at: When your prescriber and the evidence disagree Replied, post #48 · Clinical › Prescriber conversations · 10 Jul 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #34 · Compounds › Retatrutide · 3 Jul 2026 · 25 likes post #33 is right about the mechanism and I think understates the practical bit. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is…
Personal or family history of medullary thyroid carcinoma Replied, post #33 · Safety › Contraindications · 30 Jun 2026 · 0 likes post #32 answers the question as asked. The question underneath it is different. Medullary thyroid carcinoma (personal or family history) or multiple endocrine…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #31 · Analytics › Impurities & related substances · 28 Jun 2026 · 3 likes post #30 is right about the mechanism and I think understates the practical bit. Off-target structures: if the sequence synthesis goes wrong, a completely different…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #60 · Meta › Announcements · 7 Jun 2026 · 10 likes post #59 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
What I would want from a home test that does not exist yet — what changed since Replied, post #40 · Analytics › Home & field testing · 2 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #9 · Pharmacology › Pharmacokinetics · 30 May 2026 · 16 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
When a dose reduction is the correct response to a side effect Replied, post #23 · Practice › Dosing & titration · 24 May 2026 · 13 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
The anatomy of a question that gets answered within an hour Replied, post #51 · Start Here › How to Ask · 20 May 2026 · 2 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
Choosing which test to pay for, given a fixed budget Replied, post #69 · Sourcing › Independent verification · 14 Apr 2026 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Follow-up: State-level differences that actually matter Replied, post #46 · Regional › North America · 6 Apr 2026 · 6 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance.
Revisiting: Drawing up with one needle and injecting with another Replied, post #56 · Practice › Administration · 6 Apr 2026 · 14 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
The "under review" status pill and when a moderator applies it Replied, post #18 · Evidence › Preprints · 13 Mar 2026 · 25 likes post #17 is right about the mechanism and I think understates the practical bit. What changes between preprint and publication: authors respond to reviewer comments,…
Personal import allowances, compared — a second dataset Replied, post #77 · Access › International · 1 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Pregnancy and pregnancy planning: contraindication and washout Replied, post #57 · Clinical › Special populations · 28 Feb 2026 · 7 likes Worth separating two things that post #53 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #65 · Practice › Dosing & titration · 18 Feb 2026 · 27 likes On post #61 — agreed on the reasoning, with one qualification. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #67 · Compounds › Semaglutide · 14 Feb 2026 · 0 likes On post #63 — agreed on the reasoning, with one qualification. On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and…
Trifluoroacetate content and its consequences Replied, post #102 · Analytics › Impurities & related substances · 7 Feb 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #45 · Practice › Interactions · 2 Feb 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #87 · Clinical › Special populations · 25 Jan 2026 · 15 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
[2026 update] What a good consultation looks like from the other side Replied, post #13 · Clinical › Prescriber conversations · 25 Jan 2026 · 31 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #83 · Clinical › Special populations · 24 Jan 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #50 · Clinical › Bloodwork · 13 Jan 2026 · 1 like Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
MHRA statements, read directly Replied, post #66 · Regional › UK & Ireland · 11 Jan 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #33 · Devices › Pens & autoinjectors · 17 Dec 2025 · 15 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
Heterogeneity as information rather than as a nuisance Replied, post #24 · Evidence › Meta-analyses · 13 Dec 2025 · 15 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #23 · Practice › Side effects · 25 Nov 2025 · 0 likes This follows post #20 rather than contradicting it. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not…
Pen dose counters: what a click does and does not guarantee Replied, post #119 · Devices › Pens & autoinjectors · 20 Nov 2025 · 26 likes post #118 answers the question as asked. The question underneath it is different. Injection duration: most pens deliver the dose over several seconds. Holding the…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #89 · Sourcing › Vendor reports · 10 Nov 2025 · 11 likes This follows post #86 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 10 Nov 2025 · 8 likes Picking up post #6: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Second pass at: The mass-error checker and its intended scope Replied, post #44 · Data & Tools › Calculators · 22 Oct 2025 · 0 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 9 likes On post #76 — agreed on the reasoning, with one qualification. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety…
Waist circumference technique and its repeatability Replied, post #2 · Outcomes › Progress reports · 23 Sep 2025 · 7 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #55 · Evidence › Journal club · 28 Aug 2025 · 29 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #47 · Practice › Reconstitution · 24 Aug 2025 · 0 likes On post #43 — agreed on the reasoning, with one qualification. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
Revisiting: List price versus negotiated price versus what you pay Replied, post #4 · Access › Pricing · 2 Aug 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. Insurance tier placement: a compound might be covered but on a higher tier (higher…
Coming back to: What published stability data actually covers, and what it does not Replied, post #101 · Practice › Storage & stability · 31 Jul 2025 · 9 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
High-resolution MS on aggregates and what it can see Replied, post #29 · Analytics › Mass spectrometry · 24 Jul 2025 · 13 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #21 · Compounds › Semaglutide · 7 Jul 2025 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #30 · Analytics › Mass spectrometry · 29 Jun 2025 · 12 likes On post #26 — agreed on the reasoning, with one qualification. Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #60 · Evidence › Journal club · 28 Jun 2025 · 18 likes This follows post #57 rather than contradicting it. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for…
Repeatability versus intermediate precision Replied, post #22 · Analytics › Method validation · 20 Jun 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Stability-indicating method: one that can separate a compound from its degradation products. Critical…
Repeatability versus intermediate precision Replied, post #6 · Analytics › Method validation · 17 Jun 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #109 · Compounds › Tirzepatide · 13 Jun 2025 · 8 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #97 · Compounds › Tirzepatide · 30 May 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Designing a personal experiment that could change your mind Replied, post #16 · Research Methods › N-of-1 designs · 18 May 2025 · 13 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #68 · Practice › Reconstitution · 8 May 2025 · 23 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
When to stop reading forums, including this one — the long version Replied, post #5 · Wellbeing › Mental health · 29 Apr 2025 · 0 likes This follows post #2 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #7 · Wellbeing › Mental health · 22 Apr 2025 · 0 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #45 · Compounds › Secretagogues & GH axis · 18 Apr 2025 · 1 like post #44 is right about the mechanism and I think understates the practical bit. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
Validating a calculator against hand arithmetic — what changed since Replied, post #14 · Data & Tools › Calculators · 13 Apr 2025 · 20 likes post #13 answers the question as asked. The question underneath it is different. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
Validating a method you did not develop — does this still hold? Replied, post #134 · Analytics › Method validation · 19 Mar 2025 · 31 likes Picking up post #131: that is the part I would want checked first. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
Retatrutide dose escalation in the published trials Replied, post #24 · Compounds › Retatrutide · 18 Mar 2025 · 0 likes Worth separating two things that post #20 runs together. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #41 · Sourcing › Vendor reports · 16 Mar 2025 · 3 likes On post #37 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #87 · Compounds › Semaglutide · 4 Mar 2025 · 20 likes post #86 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Cost per milligram, computed honestly across formats — the long version Replied, post #22 · Access › Pricing · 2 Mar 2025 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
How compounding permissions changed when supply normalised Replied, post #23 · Sourcing › Regulatory · 24 Feb 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Consistent declarations and why they matter more than clever ones Replied, post #76 · Sourcing › Logistics · 23 Feb 2025 · 16 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 30 Jan 2025 · 7 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
A promotion I argued against, and why I lost Replied, post #72 · Documentation › Doc review · 24 Jan 2025 · 22 likes post #71 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #10 · Clinical › Bloodwork · 6 Jan 2025 · 28 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Coming back to: When to suspect the method rather than the sample Replied, post #49 · Analytics › Method validation · 9 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Washout with a one-week half-life: the arithmetic Replied, post #93 · Research Methods › N-of-1 designs · 9 Dec 2024 · 17 likes Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect generalises to others similar to you, much less to people…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #53 · Evidence › Journal club · 7 Dec 2024 · 3 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Turnaround times and what they mean for a decision — one year on Replied, post #19 · Sourcing › Independent verification · 5 Dec 2024 · 16 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #2 · Evidence › Meta-analyses · 1 Dec 2024 · 0 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #42 · Meta › Wiki maintenance · 20 Nov 2024 · 2 likes Coming back to post #40, because the follow-up matters more than the original answer. Scope creep: if a page is attempting too much, suggesting it split into multiple…
EMA product information as a primary source — does this still hold? Replied, post #30 · Regional › European Union · 15 Nov 2024 · 1 like Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #111 · Access › Shortages · 13 Oct 2024 · 3 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
When a red flag was a misunderstanding, and the retraction Replied, post #13 · Sourcing › Red flags · 7 Sep 2024 · 8 likes On post #9 — agreed on the reasoning, with one qualification. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating…
Circumference measurements as a poor man's composition estimate Replied, post #24 · Outcomes › Body composition · 28 Jul 2024 · 7 likes On post #20 — agreed on the reasoning, with one qualification. Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and…
Cold packs, phase-change material, and what survives ten days Replied, post #125 · Sourcing › Logistics · 20 Jul 2024 · 5 likes post #124 answers the question as asked. The question underneath it is different. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #11 · Compounds › Retatrutide · 16 Jul 2024 · 1 like Picking up post #8: that is the part I would want checked first. Dose escalation in the published trials: the protocols started at lower doses and escalated by defined…
How this community labels and discusses unrefereed work Replied, post #48 · Evidence › Preprints · 29 Jun 2024 · 3 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…